• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITHS HEALTHCARE MANUFACTURING S.A. DE C.V. CADD ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITHS HEALTHCARE MANUFACTURING S.A. DE C.V. CADD ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 21-7324-24
Medical Device Problem Codes Failure to Prime (1492); Obstruction of Flow (2423)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/01/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the tubing had been unable to be primed using the cadd pump; the pump read "upstream occlusion." despite the tubing being reseated and the bag being appropriately spiked, the issue persisted.A second tubing had to be used, which worked.The event occurred during priming.
 
Additional Manufacturer Narrative
B3: unknown.H3: device not received by manufacturer.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.
 
Additional Manufacturer Narrative
D9 - date returned to mfg : 6/13/2025.Two (2) used device was received for evaluation.No damage or anomalies were observed during the initial assessment.Upon closer inspection under magnification, the tubing-spike connection was inspected.The complaint of an upstream occlusion alarm can be confirmed.The probable cause is due to excess solvent application at the tubing-spike.For the first set, a partial blockage was observed.For the second set, a solvent membrane was observed at the location.A device history record (dhr) review was conducted which indicated all inspections were completed and no issues were noted during manufacture.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CADD ADMINISTRATION SET
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
SMITHS HEALTHCARE MANUFACTURING S.A. DE C.V.
ave calidad no. 4, parque
tijuana
MX 
Manufacturer Contact
reed covert
6000 nathan lane north
minneapolis, MN 55442
2247062300
MDR Report Key22143945
Report Number3012307300-2025-06608
Device Sequence Number12797084
Product Code FPA
UDI-Device Identifier10610586029653
UDI-Public(01)10610586029653(17)300114(10)6077159
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K040636
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 08/11/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number21-7324-24
Device Lot Number6077159
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/09/2025
Supplement Date Received by Manufacturer07/25/2025
Initial Report FDA Received Date06/04/2025
Supplement Report FDA Received Date08/11/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/15/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-